Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hearing results from endolymphatic sac surgery.

D W Goin1, R E Mischke, B A Esses

  • 1Denver Ear Associates, Englewood, CO 80110.

The American Journal of Otology
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.

Cancer·2001
Same author

Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase.

Infection and immunity·2000
Same author

Wrestling with typology: penetrating the "black box" of managed care by focusing on health care system characteristics.

Medical care research and review : MCRR·2000
Same author

The predictability of corneal flap thickness and tissue laser ablation in laser in situ keratomileusis.

Ophthalmology·2000
Same author

c-Jun promotes neurite outgrowth and survival in PC12 cells.

Brain research. Molecular brain research·2000

Endolymphatic shunt surgery for vertigo did not significantly impact long-term hearing outcomes. Analysis showed no significant difference in hearing loss between shunt patients and a control group, indicating the procedure does not alter hearing results.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Audiology

Background:

  • Intractable vertigo often necessitates surgical intervention, with endolymphatic shunt procedures being a common treatment.
  • The potential impact of these shunts on auditory function remains a critical consideration for patient management.

Purpose of the Study:

  • To evaluate the long-term effects of endolymphatic shunt surgery on hearing in patients with intractable vertigo.
  • To compare hearing outcomes in patients who underwent shunt surgery versus those who did not.

Main Methods:

  • A cohort study comparing 30 ears undergoing endolymphatic shunt surgery with 30 control ears.
  • Hearing was assessed using pure-tone average (PTA) and speech discrimination (SD) scores, analyzed per 1985 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) criteria.

Related Experiment Videos

  • Audiometric data included worst preoperative, worst postoperative, and long-term follow-up (up to 2 years) scores.

    • Main Results:

    • No significant difference in hearing loss (average 9 dB PTA, 16% SD) was observed between the shunt group and control group when comparing worst preoperative to worst postoperative/follow-up scores.
    • A statistically significant difference favoring the control group was found when comparing the control group's initial and final audiograms (PTA improved 2 dB, SD dropped 5%) against the shunt group's worst preoperative and postoperative scores.
    • The proportion of patients experiencing hearing improvement, stability, or worsening did not differ significantly between the two groups.

    Conclusions:

    • Endolymphatic shunt surgery does not appear to significantly affect long-term hearing preservation or deterioration in patients with intractable vertigo.
    • Hearing outcomes in patients with severe vertigo symptoms are comparable whether or not they undergo endolymphatic shunt surgery.